These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 39030748)

  • 1. Temporal progression of tau pathology and neuroinflammation in a rhesus monkey model of Alzheimer's disease.
    Beckman D; Diniz GB; Ott S; Hobson B; Chaudhari AJ; Muller S; Chu Y; Takano A; Schwarz AJ; Yeh CL; McQuade P; Chakrabarty P; Kanaan NM; Quinton MS; Simen AA; Kordower JH; Morrison JH
    Alzheimers Dement; 2024 Aug; 20(8):5198-5219. PubMed ID: 39030748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel tau-based rhesus monkey model of Alzheimer's pathogenesis.
    Beckman D; Chakrabarty P; Ott S; Dao A; Zhou E; Janssen WG; Donis-Cox K; Muller S; Kordower JH; Morrison JH
    Alzheimers Dement; 2021 Jun; 17(6):933-945. PubMed ID: 33734581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nonhuman primate model with Alzheimer's disease-like pathology induced by hippocampal overexpression of human tau.
    Jiang Z; Wang J; Qin Y; Liu S; Luo B; Bai F; Wei H; Zhang S; Wei J; Ding G; Ma L; He S; Chen R; Sun Y; Chen Y; Wang L; Xu H; Wang X; Chen G; Lei W
    Alzheimers Res Ther; 2024 Jan; 16(1):22. PubMed ID: 38281031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau seeds from Alzheimer's disease brains trigger tau spread in macaques while oligomeric-Aβ mediates pathology maturation.
    Darricau M; Dou C; Kinet R; Zhu T; Zhou L; Li X; Bedel A; Claverol S; Tokarski C; Katsinelos T; McEwan WA; Zhang L; Gao R; Bourdenx M; Dehay B; Qin C; Bezard E; Planche V
    Alzheimers Dement; 2024 Mar; 20(3):1894-1912. PubMed ID: 38148705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.
    Malpetti M; Kievit RA; Passamonti L; Jones PS; Tsvetanov KA; Rittman T; Mak E; Nicastro N; Bevan-Jones WR; Su L; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2020 May; 143(5):1588-1602. PubMed ID: 32380523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects.
    Leng F; Hinz R; Gentleman S; Dani M; Brooks DJ; Edison P
    J Alzheimers Dis; 2024; 100(3):973-986. PubMed ID: 39031352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aged rhesus macaque manifests Braak stage III/IV Alzheimer's-like pathology.
    Paspalas CD; Carlyle BC; Leslie S; Preuss TM; Crimins JL; Huttner AJ; van Dyck CH; Rosene DL; Nairn AC; Arnsten AFT
    Alzheimers Dement; 2018 May; 14(5):680-691. PubMed ID: 29241829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease.
    Sun XY; Li LJ; Dong QX; Zhu J; Huang YR; Hou SJ; Yu XL; Liu RT
    J Neuroinflammation; 2021 Jun; 18(1):131. PubMed ID: 34116706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.
    Rodriguez-Vieitez E; Kumar A; Malarte ML; Ioannou K; Rocha FM; Chiotis K
    Methods Mol Biol; 2024; 2785():195-218. PubMed ID: 38427196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer's disease.
    Olajide OJ; Suvanto ME; Chapman CA
    Biol Open; 2021 Jan; 10(1):. PubMed ID: 33495355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Sanabria Bohórquez S; Marik J; Ogasawara A; Tinianow JN; Gill HS; Barret O; Tamagnan G; Alagille D; Ayalon G; Manser P; Bengtsson T; Ward M; Williams SP; Kerchner GA; Seibyl JP; Marek K; Weimer RM
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2077-2089. PubMed ID: 31254035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
    Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ
    Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis identifies HSP90AA1, PTK2B, and ANXA2 in the human entorhinal cortex in Alzheimer's disease: Potential role in synaptic homeostasis and Aβ pathology through microglial and astroglial cells.
    Astillero-Lopez V; Villar-Conde S; Gonzalez-Rodriguez M; Flores-Cuadrado A; Ubeda-Banon I; Saiz-Sanchez D; Martinez-Marcos A
    Brain Pathol; 2024 Jul; 34(4):e13235. PubMed ID: 38247340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains.
    Quesnel MJ; Labonté A; Picard C; Zetterberg H; Blennow K; Brinkmalm A; Villeneuve S; Poirier J; ;
    Brain; 2024 May; 147(5):1680-1695. PubMed ID: 37992295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
    Gordon BA; Blazey TM; Christensen J; Dincer A; Flores S; Keefe S; Chen C; Su Y; McDade EM; Wang G; Li Y; Hassenstab J; Aschenbrenner A; Hornbeck R; Jack CR; Ances BM; Berman SB; Brosch JR; Galasko D; Gauthier S; Lah JJ; Masellis M; van Dyck CH; Mintun MA; Klein G; Ristic S; Cairns NJ; Marcus DS; Xiong C; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
    Brain; 2019 Apr; 142(4):1063-1076. PubMed ID: 30753379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates.
    Darricau M; Katsinelos T; Raschella F; Milekovic T; Crochemore L; Li Q; Courtine G; McEwan WA; Dehay B; Bezard E; Planche V
    Brain; 2023 Jun; 146(6):2524-2534. PubMed ID: 36382344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration.
    Fernández-Cabello S; Kronbichler M; Van Dijk KRA; Goodman JA; Spreng RN; Schmitz TW;
    Brain; 2020 Mar; 143(3):993-1009. PubMed ID: 32203580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's Disease.
    Horie K; Li Y; Barthélemy NR; Gordon B; Hassenstab J; Benzinger TLS; Fagan AM; Morris JC; Karch CM; Xiong C; Allegri R; Mendez PC; Ikeuchi T; Kasuga K; Noble J; Farlow M; Chhatwal J; Day G; Schofield PR; Masters CL; Levin J; Jucker M; Lee JH; Roh JH; Sato C; Sachdev P; Koyama A; Reyderman L; Bateman RJ; McDade E;
    Ann Neurol; 2023 Jun; 93(6):1158-1172. PubMed ID: 36843330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer's Disease.
    Klein J; Yan X; Johnson A; Tomljanovic Z; Zou J; Polly K; Honig LS; Brickman AM; Stern Y; Devanand DP; Lee S; Kreisl WC
    J Alzheimers Dis; 2021; 80(3):1051-1065. PubMed ID: 33646153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.